Tirzepatide
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Eli Lilly · Phase 2 · Active, not recruiting · Enrollment 414
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide High Dose 1 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Tirzepatide High Dose 2 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Tirzepatide | Obesity + T2D | n/r | n/r | n/r | n/r |
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |